HAO
HAO
Haoxi Health Technology LimitedIncome Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2026 | $33.83M ▲ | $7.28M ▲ | $-6.88M ▼ | -20.34% ▼ | $-1.53 ▼ | $-5.42M ▼ |
| Q4-2025 | $8.85M ▼ | $2.32M ▲ | $4.11M ▲ | 46.44% ▲ | $1.42 ▲ | $4.2M ▲ |
| Q2-2025 | $23.95M ▼ | $607.74K ▼ | $-232.53K ▼ | -0.97% ▼ | $-0.01 ▼ | $11.61K ▼ |
| Q4-2024 | $25.02M ▲ | $650.11K ▲ | $529.8K ▼ | 2.12% ▼ | $0.04 ▼ | $959.42K ▲ |
| Q2-2024 | $23.5M | $383.02K | $760.2K | 3.23% | $0.06 | $829.96K |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2026 | $6.8M ▼ | $20.66M ▼ | $4.7M ▲ | $15.96M ▼ |
| Q4-2025 | $8.62M ▼ | $21.6M ▼ | $4.22M ▲ | $17.38M ▼ |
| Q2-2025 | $9.1M ▲ | $22.07M ▲ | $3.32M ▼ | $18.74M ▲ |
| Q4-2024 | $6.66M ▲ | $15.51M ▲ | $4.23M ▼ | $11.27M ▲ |
| Q2-2024 | $1.11M | $6.17M | $4.45M | $1.72M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2026 | $-6.88M ▼ | $-2.27M ▼ | $-4.5M ▼ | $4.93M ▲ | $-1.82M ▼ | $-2.27M ▼ |
| Q4-2025 | $4.11M ▲ | $-1.11M ▲ | $-505.18K ▲ | $1.16M ▼ | $-477.96K ▼ | $-1.1M ▲ |
| Q2-2025 | $-232.53K ▼ | $-2.25M ▼ | $-3.07M ▲ | $7.75M ▼ | $2.44M ▼ | $-2.26M ▼ |
| Q4-2024 | $531.47K ▼ | $-1.05M ▼ | $-3.11M ▼ | $9.08M ▲ | $5.54M ▲ | $-1.09M ▼ |
| Q2-2024 | $760.2K | $301K | $-16.16K | $239.4K | $1.11M | $284.84K |
5-Year Trend Analysis
A comprehensive look at Haoxi Health Technology Limited's financial evolution and strategic trajectory over the past five years.
The company has several notable positives: a transformed balance sheet with strong cash reserves and low leverage; a clear niche focus in healthcare digital advertising; proprietary technology and established platform relationships; and a track record of rapid historical growth and improving reported earnings through 2024. Its asset-light model and strong liquidity give it flexibility to experiment with new services such as livestreaming without immediate financing stress.
The most significant risks center on operations and cash. Revenue has become volatile, with a sharp drop in the latest year. Operating profit has turned negative, overhead has surged, and gross profits have come under pressure, pointing to execution or demand challenges. Cash flow from operations and free cash flow have been negative for several years, leaving the company reliant on equity financing. In addition, regulatory uncertainty in healthcare advertising, intense competition, and the need to continually refresh technology all add to the risk profile.
The outlook is mixed and uncertain. On one hand, Haoxi sits in a growing structural niche with differentiated capabilities, a strong liquidity cushion, and promising innovation in tools and livestreaming services. On the other, the current business model is not yet generating reliable operating profits or cash, and recent financial trends have moved in the wrong direction. Future performance will depend on the company’s ability to stabilize revenue, rein in costs, convert its specialized offerings into recurring, high-quality business, and turn accounting profits into sustainable cash flows.
About Haoxi Health Technology Limited
https://www.haoximedia.comHaoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2026 | $33.83M ▲ | $7.28M ▲ | $-6.88M ▼ | -20.34% ▼ | $-1.53 ▼ | $-5.42M ▼ |
| Q4-2025 | $8.85M ▼ | $2.32M ▲ | $4.11M ▲ | 46.44% ▲ | $1.42 ▲ | $4.2M ▲ |
| Q2-2025 | $23.95M ▼ | $607.74K ▼ | $-232.53K ▼ | -0.97% ▼ | $-0.01 ▼ | $11.61K ▼ |
| Q4-2024 | $25.02M ▲ | $650.11K ▲ | $529.8K ▼ | 2.12% ▼ | $0.04 ▼ | $959.42K ▲ |
| Q2-2024 | $23.5M | $383.02K | $760.2K | 3.23% | $0.06 | $829.96K |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2026 | $6.8M ▼ | $20.66M ▼ | $4.7M ▲ | $15.96M ▼ |
| Q4-2025 | $8.62M ▼ | $21.6M ▼ | $4.22M ▲ | $17.38M ▼ |
| Q2-2025 | $9.1M ▲ | $22.07M ▲ | $3.32M ▼ | $18.74M ▲ |
| Q4-2024 | $6.66M ▲ | $15.51M ▲ | $4.23M ▼ | $11.27M ▲ |
| Q2-2024 | $1.11M | $6.17M | $4.45M | $1.72M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2026 | $-6.88M ▼ | $-2.27M ▼ | $-4.5M ▼ | $4.93M ▲ | $-1.82M ▼ | $-2.27M ▼ |
| Q4-2025 | $4.11M ▲ | $-1.11M ▲ | $-505.18K ▲ | $1.16M ▼ | $-477.96K ▼ | $-1.1M ▲ |
| Q2-2025 | $-232.53K ▼ | $-2.25M ▼ | $-3.07M ▲ | $7.75M ▼ | $2.44M ▼ | $-2.26M ▼ |
| Q4-2024 | $531.47K ▼ | $-1.05M ▼ | $-3.11M ▼ | $9.08M ▲ | $5.54M ▲ | $-1.09M ▼ |
| Q2-2024 | $760.2K | $301K | $-16.16K | $239.4K | $1.11M | $284.84K |
5-Year Trend Analysis
A comprehensive look at Haoxi Health Technology Limited's financial evolution and strategic trajectory over the past five years.
The company has several notable positives: a transformed balance sheet with strong cash reserves and low leverage; a clear niche focus in healthcare digital advertising; proprietary technology and established platform relationships; and a track record of rapid historical growth and improving reported earnings through 2024. Its asset-light model and strong liquidity give it flexibility to experiment with new services such as livestreaming without immediate financing stress.
The most significant risks center on operations and cash. Revenue has become volatile, with a sharp drop in the latest year. Operating profit has turned negative, overhead has surged, and gross profits have come under pressure, pointing to execution or demand challenges. Cash flow from operations and free cash flow have been negative for several years, leaving the company reliant on equity financing. In addition, regulatory uncertainty in healthcare advertising, intense competition, and the need to continually refresh technology all add to the risk profile.
The outlook is mixed and uncertain. On one hand, Haoxi sits in a growing structural niche with differentiated capabilities, a strong liquidity cushion, and promising innovation in tools and livestreaming services. On the other, the current business model is not yet generating reliable operating profits or cash, and recent financial trends have moved in the wrong direction. Future performance will depend on the company’s ability to stabilize revenue, rein in costs, convert its specialized offerings into recurring, high-quality business, and turn accounting profits into sustainable cash flows.

CEO
Lei Xu
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2026-05-21 | Reverse | 1:128 |
| 2025-01-27 | Reverse | 1:25 |
Ratings Snapshot
Rating : C+

